The importance of PU.1 concentration in hematopoietic lineage commitment and maturation

被引:62
作者
Dahl, R [1 ]
Simon, MC [1 ]
机构
[1] Univ Penn, Sch Med, Abramson Family Canc Res Ctr, Howard Hughes Med Inst, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/S1079-9796(03)00152-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PU.1 is an Ets family transcription factor that is required for the development of myeloid and lymphoid cells. Since PU.1 is required for several different lineages it has been unclear what role PU.1 has in deciding whether a hematopoietic progenitor cell differentiates into a macrophage, granulocyte, or B cell. Recent studies have demonstrated that different cellular concentrations of PU.1 may direct distinct cell fates, with the highest concentrations of PU.1 required for macrophage development and lower concentrations for granulocytic and B-cell fate adoption. Since PU.1 transactivation activity is inhibited by the granulocytic factor, C/EBPalpha and the B-cell factor BSAP, high concentrations of PU.1 may be required for macrophage development in order to overcome the negative effects of alternative lineage specific factors. Lastly, PU.1 Upregulation is implicated in the maturation of myeloid cells once they have committed to the macrophage and granulocytic lineages. PU.1 activity is inhibited in some cases of acute myelogenous leukemia (AML), therefore, inhibition of PU.1 induced maturation may he a critical step in leukemogenesis. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:229 / 233
页数:5
相关论文
共 42 条
[1]   ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain [J].
Amann, JM ;
Nip, J ;
Strom, DK ;
Lutterbach, B ;
Harada, H ;
Lenny, N ;
Downing, JR ;
Meyers, S ;
Hiebert, SW .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (19) :6470-6483
[2]   Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage [J].
Anderson, MK ;
Weiss, AH ;
Hernandez-Hoyos, G ;
Dionne, CJ ;
Rothenberg, EV .
IMMUNITY, 2002, 16 (02) :285-296
[3]   The in vivo profile of transcription factors during neutrophil differentiation in human bone marrow [J].
Bjerregaard, MD ;
Jurlander, J ;
Klausen, P ;
Borregaard, N ;
Cowland, JB .
BLOOD, 2003, 101 (11) :4322-4332
[4]   Hematopoietic development: a balancing act [J].
Cantor, AB ;
Orkin, SH .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2001, 11 (05) :513-519
[5]   BSAP/Pax5A expression blocks survival and expansion of early myeloid cells implicating its involvement in maintaining commitment to the B-lymphocyte lineage [J].
Chiang, MY ;
Monroe, JG .
BLOOD, 1999, 94 (11) :3621-3632
[6]   THE ESTABLISHMENT AND INTERPRETATION OF TRANSCRIPTION FACTOR GRADIENTS IN THE DROSOPHILA EMBRYO [J].
COUREY, AJ ;
HUANG, JD .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1995, 1261 (01) :1-18
[7]   Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types [J].
Dasen, JS ;
O'Connell, SM ;
Flynn, SE ;
Treier, M ;
Gleiberman, AS ;
Szeto, DP ;
Hooshmand, F ;
Aggarwal, AK ;
Rosenfeld, MG .
CELL, 1999, 97 (05) :587-598
[8]   Signaling and transcriptional mechanisms in pituitary development [J].
Dasen, JS ;
Rosenfeld, MG .
ANNUAL REVIEW OF NEUROSCIENCE, 2001, 24 :327-355
[9]   Regulation of B lymphocyte and macrophage development by graded expression of PU.1 [J].
DeKoter, RP ;
Singh, H .
SCIENCE, 2000, 288 (5470) :1439-1441
[10]   Transcriptional regulation of granulocyte and monocyte development [J].
Friedman, AD .
ONCOGENE, 2002, 21 (21) :3377-3390